ArticleYonsei medical journal2026
Urinary Albumin-to-Creatinine Ratio and Risk of Incident Cardiovascular Disease in the KoGES-ARIRANG Community-Based Cohort.
Article in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeWe aimed to assess whether low-grade albuminuria, characterized by a low urinary albumin-to-creatinine ratio (UACR) within the normal range (<30 mg/g), could predict cardiovascular disease (CVD) risk in a low-risk general population, with an emphasis on sex- and menopause-specific differences. MATERIALS AND
methodsWe analyzed data from 1327 participants from the Korean Genome and Epidemiology Study, excluding individuals with known CVD or major chronic illnesses, who were followed up for a median of 6.37 years. The UACR was measured from spot urine samples and treated as a continuous variable. The cardiovascular outcomes included stroke, myocardial infarction, and angina. Cox proportional hazards models and restricted cubic spline analyses were used to assess the association between UACR and incident CVD, stratified by sex and menopausal status.
resultsNo significant association was observed between UACR and CVD in men or premenopausal women. However, in postmenopausal women, UACR was significantly associated with incident CVD (adjusted hazard ratio 1.09; 95% confidence interval: 1.01-1.18 per 1 mg/g increase). Spline analyses revealed a clear dose-response relationship in postmenopausal women, whereas no such pattern was observed in the other subgroups. Covariate-stratified analyses suggested a potential interaction effect of body mass index, blood pressure, and lipid profile.
conclusionLow-grade albuminuria may serve as an early biomarker of cardiovascular risk in otherwise healthy individuals, particularly in subgroups susceptible to hormonal or metabolic changes. Routine UACR screening may be a practical tool for early risk stratification and prevention of CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.